Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000697495 | SCV000826110 | uncertain significance | Fanconi anemia | 2022-12-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 575313). This variant has not been reported in the literature in individuals affected with SLX4-related conditions. This variant is present in population databases (rs373231418, gnomAD 0.003%). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1079 of the SLX4 protein (p.Pro1079Ser). |
Prevention |
RCV003420237 | SCV004106542 | uncertain significance | SLX4-related disorder | 2023-06-14 | criteria provided, single submitter | clinical testing | The SLX4 c.3235C>T variant is predicted to result in the amino acid substitution p.Pro1079Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0031% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-3640404-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |